These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11781302)

  • 1. Interferon treatment of HCV: do we need a virological response?
    Blendis L; Oren R; Halpern Z
    Gastroenterology; 2002 Jan; 122(1):237-8. PubMed ID: 11781302
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and anticarcinogenic activity of ribavirin combination therapy for hepatitis C virus-related compensated cirrhosis.
    Akuta N; Suzuki F; Seko Y; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    Intervirology; 2013; 56(1):37-45. PubMed ID: 23037768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A la carte interferon for hepatitis C?
    Marcellin P; Benhamou JP; Heathcote J; Bismuth H; Desmet V; Guardia J; Lok A; Buschenfeld KH; Pagliaro L; Paumgartner G; Rodes J; Sherlock S
    Hepatology; 2000 Sep; 32(3):678-9. PubMed ID: 10991636
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic factors predicting response to interferon treatment for viral hepatitis C.
    Stärkel P
    Gut; 2008 Apr; 57(4):440-2. PubMed ID: 18334658
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of interferon in the treatment of viral hepatitis and its perspective].
    Zhang DF
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):2-4. PubMed ID: 21272448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of pegylated-interferon in the treatment of hepatitis C in Chinese patients].
    Dou X; Wei L; Ren H; Zhang H; Zhang W; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2015 Sep; 23(9):641-3. PubMed ID: 26524354
    [No Abstract]   [Full Text] [Related]  

  • 10. Should acute viral C hepatitis be treated with interferon?
    Desai HG; Gupte PA
    Indian J Gastroenterol; 2005; 24(2):66-7. PubMed ID: 15879653
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.
    Bonny C; Fontaine H; Poynard T; Hézode C; Larrey D; Marcellin P; Bourlière M; Bronowicki JP; Merle P; Zarski JP; Sapey T; Guillemard C; Ughetto S; Henquell C; Nicolas C; Roche C; Randl K; Bommelaer G; Abergel A
    Aliment Pharmacol Ther; 2006 Aug; 24(4):593-600. PubMed ID: 16907892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic improvement of fibrosis in patients with hepatitis C and sustained response to interferon therapy.
    Bolaños-Meade J; López-Arvizu C
    Ann Intern Med; 2000 Aug; 133(4):312. PubMed ID: 10929184
    [No Abstract]   [Full Text] [Related]  

  • 13. [The combination administration of interferon in viral hepatitis].
    Zhao GD; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):5-7. PubMed ID: 21272449
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C Virus and Interferon-Free Antiviral Therapeutics Revolution: Implications for Pakistan.
    Afzal MS
    Viral Immunol; 2017 May; 30(4):252-257. PubMed ID: 28118096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C.
    Krämer B; Nischalke HD; Boesecke C; Ingiliz P; Voigt E; Mauss S; Stellbrink HJ; Baumgarten A; Rockstroh JK; Spengler U; Nattermann J
    AIDS; 2013 Nov; 27(17):2817-9. PubMed ID: 23939236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin priming improves the virological response to antiviral treatment in transplanted patients with recurrent hepatitis C: a pilot study.
    Merli M; Giannelli V; Gentili F; Giusto M; Simmaco M; Lionetto L; Corradini SG; Biliotti E; Attili AF; Rossi M; Taliani G
    Antivir Ther; 2011; 16(6):879-85. PubMed ID: 21900720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients.
    Donato MF; Bastiampillai AJ; Manini M; Monico S
    J Antimicrob Chemother; 2013 Apr; 68(4):974-5. PubMed ID: 23221629
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and Treatment of Untypable HCV Variants in Different Districts of Punjab, Pakistan.
    Zafar A; Imran M; Zahoor S; Shah ZH; Ali M; Afzal MS
    Viral Immunol; 2018; 31(6):426-432. PubMed ID: 29920175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial Commentary: Interferon-free Hepatitis C Treatment Efficacy From Clinical Trials Will Translate to "Real World" Outcomes.
    Martinello M; Dore GJ
    Clin Infect Dis; 2016 Apr; 62(7):927-8. PubMed ID: 26743092
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C virus genotype, hepatitis C virus RNA titers, and response to interferon.
    Taliani G; Badolato MC; Pasquazzi C
    Ann Intern Med; 1997 Jul; 127(1):89. PubMed ID: 9214263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.